Latent Classes of Cognitive Functioning Among Depressed Older Adults Without Dementia.


Journal

Journal of the International Neuropsychological Society : JINS
ISSN: 1469-7661
Titre abrégé: J Int Neuropsychol Soc
Pays: England
ID NLM: 9503760

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 25 6 2019
medline: 10 9 2020
entrez: 25 6 2019
Statut: ppublish

Résumé

Use latent class analysis (LCA) to identify patterns of cognitive functioning in a sample of older adults with clinical depression and without dementia and assess demographic, psychiatric, and neurobiological predictors of class membership. Neuropsychological assessment data from 121 participants in the Alzheimer's Disease Neuroimaging Initiative-Depression project (ADNI-D) were analyzed, including measures of executive functioning, verbal and visual memory, visuospatial and language functioning, and processing speed. These data were analyzed using LCA, with predictors of class membership such as depression severity, depression and treatment history, amyloid burden, and APOE e4 allele also assessed. A two-class model of cognitive functioning best fit the data, with the Lower Cognitive Class (46.1% of the sample) performing approximately one standard deviation below the Higher Cognitive Class (53.9%) on most tests. When predictors of class membership were assessed, carrying an APOE e4 allele was significantly associated with membership in the Lower Cognitive Class. Demographic characteristics, age of depression onset, depression severity, history of psychopharmacological treatment for depression, and amyloid positivity did not predict class membership. LCA allows for identification of subgroups of cognitive functioning in a mostly cognitively intact late life depression (LLD) population. One subgroup, the Lower Cognitive Class, more likely to carry an APOE e4 allele, may be at a greater risk for subsequent cognitive decline, even though current performance on neuropsychological testing is within normal limits. These findings have implications for early identification of those at greatest risk, risk factors, and avenues for preventive intervention.

Identifiants

pubmed: 31232250
pii: S1355617719000596
doi: 10.1017/S1355617719000596
pmc: PMC6733620
mid: NIHMS1530092
doi:

Substances chimiques

Amyloid beta-Peptides 0
Apolipoprotein E4 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

811-820

Subventions

Organisme : NIA NIH HHS
ID : P30 AG010133
Pays : United States
Organisme : NIA NIH HHS
ID : U19 AG024904
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG023501
Pays : United States
Organisme : NLM NIH HHS
ID : R01 LM011360
Pays : United States
Organisme : NIMH NIH HHS
ID : K08 MH081065
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH098062
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA129769
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG019771
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH101472
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG024904
Pays : United States
Organisme : NIA NIH HHS
ID : R44 AG049540
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG053798
Pays : United States

Références

Am J Geriatr Psychiatry. 2000 Summer;8(3):201-8
pubmed: 10910417
Am J Geriatr Psychiatry. 2001 Spring;9(2):102-12
pubmed: 11316615
J Gerontol A Biol Sci Med Sci. 2003 Mar;58(3):249-65
pubmed: 12634292
Am J Psychiatry. 2003 Aug;160(8):1516-8
pubmed: 12900317
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
pubmed: 14399272
J Gerontol A Biol Sci Med Sci. 2003 Dec;58(12):M1137-44
pubmed: 14684712
Arch Gen Psychiatry. 2004 Jun;61(6):587-95
pubmed: 15184238
Brain Res Rev. 2006 Jun;51(1):125-35
pubmed: 16378640
Arch Neurol. 2006 Mar;63(3):435-40
pubmed: 16533972
Int J Geriatr Psychiatry. 2007 Jun;22(6):563-7
pubmed: 17136705
J Neurol Neurosurg Psychiatry. 2007 Jun;78(6):638-40
pubmed: 17210630
Am J Geriatr Psychiatry. 2007 Oct;15(10):858-68
pubmed: 17911363
Am J Psychiatry. 2008 Feb;165(2):229-37
pubmed: 17986679
Neurology. 2008 Apr 8;70(15):1258-64
pubmed: 18391157
Arch Gen Psychiatry. 2008 May;65(5):542-50
pubmed: 18458206
Biol Psychiatry. 2008 Sep 15;64(6):491-7
pubmed: 18490003
Am J Geriatr Psychiatry. 2009 Feb;17(2):155-65
pubmed: 19155747
Psychol Med. 2010 Feb;40(2):225-37
pubmed: 19531277
Alzheimers Dement. 2010 May;6(3):239-46
pubmed: 20451872
Neurology. 2010 Jul 6;75(1):27-34
pubmed: 20603482
Am J Geriatr Psychiatry. 2011 Jan;19(1):4-12
pubmed: 20808107
Nat Rev Neurol. 2011 May 03;7(6):323-31
pubmed: 21537355
Mol Psychiatry. 2011 Sep;16(9):903-7
pubmed: 21556001
Arch Neurol. 2012 Jul;69(7):824-31
pubmed: 22451159
PLoS One. 2012;7(6):e38268
pubmed: 22675535
Depress Anxiety. 2012 Dec;29(12):1043-9
pubmed: 22933451
Ann Neurol. 2012 Oct;72(4):578-86
pubmed: 23109153
J Psychiatr Res. 2013 Apr;47(4):479-85
pubmed: 23312759
Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):714-22
pubmed: 24233127
Am J Geriatr Psychiatry. 2014 Dec;22(12):1633-41
pubmed: 24680502
J Int Neuropsychol Soc. 2014 May;20(5):461-7
pubmed: 24685173
Aust N Z J Psychiatry. 2015 Jan;49(1):36-46
pubmed: 25414381
JAMA. 2015 May 19;313(19):1924-38
pubmed: 25988462
J Clin Psychiatry. 2016 Jan;77(1):117-22; quiz 122
pubmed: 26845268
Age Ageing. 2016 Jul;45(4):448-56
pubmed: 27055878
Int J Geriatr Psychiatry. 2017 Apr;32(4):455-463
pubmed: 27114112
J Am Geriatr Soc. 2016 Dec;64(12):2517-2521
pubmed: 27801932
BMC Med. 2017 Apr 19;15(1):81
pubmed: 28424070
Am J Geriatr Psychiatry. 2017 Oct;25(10):1123-1134
pubmed: 28479153
JAMA Psychiatry. 2017 Jul 1;74(7):673-674
pubmed: 28514459
Mayo Clin Proc. 2017 Jun;92(6):978-994
pubmed: 28578785
PLoS Med. 2017 Jun 26;14(6):e1002334
pubmed: 28650972
Arch Gen Psychiatry. 1988 Nov;45(11):977-86
pubmed: 3263101
J Affect Disord. 1996 Jan 22;36(3-4):135-44
pubmed: 8821316

Auteurs

Ruth T Morin (RT)

San Francisco VA Medical Center, Mental Health Service, San Francisco, USA.

Philip Insel (P)

San Francisco VA Medical Center, Center for Imaging of Neurodegenerative Diseases, San Francisco, USA.
Lund University, Faculty of Medicine, Clinical Memory Research Unit, Lund, Sweden.

Craig Nelson (C)

University of California San Francisco, Department of Psychiatry, San Francisco, USA.

Meryl Butters (M)

University of Pittsburgh, Department of Psychiatry, Pittsburgh, Pennsylvania.

David Bickford (D)

University of California San Francisco, Department of Psychiatry, San Francisco, USA.

Susan Landau (S)

University of California Berkeley, Helen Wills Neuroscience Institute, Berkeley, USA.

Andrew Saykin (A)

Indiana University School of Medicine, Department of Radiology and Imaging Sciences, Indianapolis, USA.

Michael Weiner (M)

University of California San Francisco, Department of Psychiatry, San Francisco, USA.

R Scott Mackin (RS)

San Francisco VA Medical Center, Mental Health Service, San Francisco, USA.
San Francisco VA Medical Center, Center for Imaging of Neurodegenerative Diseases, San Francisco, USA.
University of California San Francisco, Department of Psychiatry, San Francisco, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH